Related Experiment Video
Updated: Aug 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial Fibrillation at Elderly Age: The Importance of Stroke Prevention
1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA.
Insights
Elderly patients with atrial fibrillation (AF) face high stroke risk. Long-term warfarin therapy significantly reduces this risk, even in older adults, with manageable bleeding complications.
Area of Science:
- Cardiology
- Geriatrics
- Neurology
Background:
- Atrial fibrillation (AF) prevalence increases with age, posing a significant stroke risk in the elderly.
- Approximately 2.2 million Americans, with a median age of 75, have AF.
- Elderly patients over 75, especially those with coronary heart disease or heart failure, are at the highest risk for embolic stroke.
Purpose of the Study:
- To evaluate the efficacy and safety of long-term warfarin therapy in reducing stroke risk in elderly patients with nonvalvular atrial fibrillation.
Main Methods:
- Review of randomized controlled trials on warfarin use in nonvalvular atrial fibrillation.
- Analysis of stroke risk reduction and bleeding complications in elderly populations.
Main Results:
- Long-term warfarin therapy substantially decreases stroke risk in patients with nonvalvular atrial fibrillation.
- The benefits of warfarin anticoagulation are maintained in elderly patients.
- Warfarin anticoagulation can be safely administered to the elderly with careful monitoring and management of concurrent therapies, resulting in an acceptably low rate of bleeding complications.
Conclusions:
- Warfarin therapy is an effective and safe strategy for stroke prevention in elderly patients with atrial fibrillation.
- Careful patient monitoring and management are crucial for optimizing warfarin therapy in older adults.
Abstract:
Atrial fibrillation increases in prevalence with advancing age and is the major precursor of embolic stroke in an elderly population. Currently about 2.2 million people in the United States have atrial fibrillation and their median age is 75 years. Patients older than 75 years of age with atrial fibrillation and those with underlying coronary heart disease or with heart failure are at highest risk of stroke. Long-term warfarin anticoagulant therapy, in a number of randomized controlled trials of its use in nonvalvular atrial fibrillation, substantially decreased stroke risk, with benefit maintained at elderly age. Warfarin anticoagulation at elderly age, with careful monitoring and attention to concomitant therapies, can be safely accomplished with an acceptably low rate of bleeding complication.
More Related Videos
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Pharmacodynamics in Geriatric Patients: Effects of Age
Coronary Artery Disease IV: Preventive Measures
Dysrhythmias VI: Management of Dysrhythmias
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

